Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Nov 12;22:298. doi: 10.1186/s12957-024-03581-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2024

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 1 — Elevated levels of mitochondrial/OXPHOS mediators correlate with poor prognosis of AML patients

A-G Kaplan-Meier survival plots of A NADH:ubiquinone oxidoreductase subunit A6 (NDUFA6), B NADH:ubiquinone oxidoreductase subunit C1 (NDUFC1), C succinate dehydrogenase complex flavoprotein subunit A (SDHA), D cytochrome B5 type A (CYB5A), E solute carrier family 25 member 12 (SLC25A12), F electron transfer flavoprotein subunit beta (ETFB) and G carnitine palmitoyltransferase 1A (CPT1A)) in AML patients with a follow-up threshold of 120 months based on KM plotter AML dataset. Samples were divided into low (blue) and high (red) expression cohorts for each gene. Hazard ratio (HR) and log-rank P values are illustrated in each plot. H HR and log-rank P values of the prognostic potential of indicated genes in AML patients based on Gene Expression Profiling Interactive Analysis (GEPIA) database